Request for Covid-19 Impact Assessment of this Report
Scope of the Report:
This report studies the Oncology Molecular Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oncology Molecular Diagnostics market by product type and applications/end industries.
Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.
The global Oncology Molecular Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncology Molecular Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
Bayer Healthcare
Beckton Dickinson
Cepheid
Dako
Danaher
Gen Probe
Qiagen
Roche Diagnostics
Siemens
Sysmex
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
PCR
INAAT
DNA sequencing & NGS
In situ hybridization
DNA microarrays
Other
Market Segment by Applications, can be divided into
Infectious diseases
oncology
Genetic tests
Other
1 Oncology Molecular Diagnostics Market Overview
1.1 Product Overview and Scope of Oncology Molecular Diagnostics
1.2 Classification of Oncology Molecular Diagnostics by Types
1.2.1 Global Oncology Molecular Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global Oncology Molecular Diagnostics Revenue Market Share by Types in 2017
1.2.3 PCR
1.2.4 INAAT
1.2.5 DNA sequencing & NGS
1.2.6 In situ hybridization
1.2.7 DNA microarrays
1.2.8 Other
1.3 Global Oncology Molecular Diagnostics Market by Application
1.3.1 Global Oncology Molecular Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Infectious diseases
1.3.3 oncology
1.3.4 Genetic tests
1.3.5 Other
1.4 Global Oncology Molecular Diagnostics Market by Regions
1.4.1 Global Oncology Molecular Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Oncology Molecular Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncology Molecular Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Molecular Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Oncology Molecular Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Molecular Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Oncology Molecular Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Oncology Molecular Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer Healthcare
2.2.1 Business Overview
2.2.2 Oncology Molecular Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Healthcare Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Beckton Dickinson
2.3.1 Business Overview
2.3.2 Oncology Molecular Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beckton Dickinson Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cepheid
2.4.1 Business Overview
2.4.2 Oncology Molecular Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cepheid Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Dako
2.5.1 Business Overview
2.5.2 Oncology Molecular Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dako Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Danaher
2.6.1 Business Overview
2.6.2 Oncology Molecular Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Danaher Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Gen Probe
2.7.1 Business Overview
2.7.2 Oncology Molecular Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Gen Probe Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Qiagen
2.8.1 Business Overview
2.8.2 Oncology Molecular Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Qiagen Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Roche Diagnostics
2.9.1 Business Overview
2.9.2 Oncology Molecular Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Roche Diagnostics Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Siemens
2.10.1 Business Overview
2.10.2 Oncology Molecular Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Siemens Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sysmex
2.11.1 Business Overview
2.11.2 Oncology Molecular Diagnostics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sysmex Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oncology Molecular Diagnostics Market Competition, by Players
3.1 Global Oncology Molecular Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Oncology Molecular Diagnostics Players Market Share
3.2.2 Top 10 Oncology Molecular Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Oncology Molecular Diagnostics Market Size by Regions
4.1 Global Oncology Molecular Diagnostics Revenue and Market Share by Regions
4.2 North America Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
5 North America Oncology Molecular Diagnostics Revenue by Countries
5.1 North America Oncology Molecular Diagnostics Revenue by Countries (2013-2018)
5.2 USA Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe Oncology Molecular Diagnostics Revenue by Countries
6.1 Europe Oncology Molecular Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Oncology Molecular Diagnostics Revenue by Countries
7.1 Asia-Pacific Oncology Molecular Diagnostics Revenue by Countries (2013-2018)
7.2 China Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
8 South America Oncology Molecular Diagnostics Revenue by Countries
8.1 South America Oncology Molecular Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Oncology Molecular Diagnostics by Countries
9.1 Middle East and Africa Oncology Molecular Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
10 Global Oncology Molecular Diagnostics Market Segment by Type
10.1 Global Oncology Molecular Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Oncology Molecular Diagnostics Market Forecast by Type (2018-2023)
10.3 PCR Revenue Growth Rate (2013-2023)
10.4 INAAT Revenue Growth Rate (2013-2023)
10.5 DNA sequencing & NGS Revenue Growth Rate (2013-2023)
10.6 In situ hybridization Revenue Growth Rate (2013-2023)
10.7 DNA microarrays Revenue Growth Rate (2013-2023)
10.8 Other Revenue Growth Rate (2013-2023)
11 Global Oncology Molecular Diagnostics Market Segment by Application
11.1 Global Oncology Molecular Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Oncology Molecular Diagnostics Market Forecast by Application (2018-2023)
11.3 Infectious diseases Revenue Growth (2013-2018)
11.4 oncology Revenue Growth (2013-2018)
11.5 Genetic tests Revenue Growth (2013-2018)
11.6 Other Revenue Growth (2013-2018)
12 Global Oncology Molecular Diagnostics Market Size Forecast (2018-2023)
12.1 Global Oncology Molecular Diagnostics Market Size Forecast (2018-2023)
12.2 Global Oncology Molecular Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Oncology Molecular Diagnostics Picture
Table Product Specifications of Oncology Molecular Diagnostics
Table Global Oncology Molecular Diagnostics and Revenue (Million USD) Market Split by Product Type
Figure Global Oncology Molecular Diagnostics Revenue Market Share by Types in 2017
Figure PCR Picture
Figure INAAT Picture
Figure DNA sequencing & NGS Picture
Figure In situ hybridization Picture
Figure DNA microarrays Picture
Figure Other Picture
Table Global Oncology Molecular Diagnostics Revenue (Million USD) by Application (2013-2023)
Figure Oncology Molecular Diagnostics Revenue Market Share by Applications in 2017
Figure Infectious diseases Picture
Figure oncology Picture
Figure Genetic tests Picture
Figure Other Picture
Table Global Market Oncology Molecular Diagnostics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Oncology Molecular Diagnostics Type and Applications
Table Abbott Laboratories Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table Bayer Healthcare Oncology Molecular Diagnostics Type and Applications
Table Bayer Healthcare Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Beckton Dickinson Basic Information, Manufacturing Base and Competitors
Table Beckton Dickinson Oncology Molecular Diagnostics Type and Applications
Table Beckton Dickinson Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Cepheid Basic Information, Manufacturing Base and Competitors
Table Cepheid Oncology Molecular Diagnostics Type and Applications
Table Cepheid Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Dako Basic Information, Manufacturing Base and Competitors
Table Dako Oncology Molecular Diagnostics Type and Applications
Table Dako Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Danaher Basic Information, Manufacturing Base and Competitors
Table Danaher Oncology Molecular Diagnostics Type and Applications
Table Danaher Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Gen Probe Basic Information, Manufacturing Base and Competitors
Table Gen Probe Oncology Molecular Diagnostics Type and Applications
Table Gen Probe Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Oncology Molecular Diagnostics Type and Applications
Table Qiagen Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table Roche Diagnostics Oncology Molecular Diagnostics Type and Applications
Table Roche Diagnostics Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Basic Information, Manufacturing Base and Competitors
Table Siemens Oncology Molecular Diagnostics Type and Applications
Table Siemens Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Sysmex Basic Information, Manufacturing Base and Competitors
Table Sysmex Oncology Molecular Diagnostics Type and Applications
Table Sysmex Oncology Molecular Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Oncology Molecular Diagnostics Revenue (Million USD) by Players (2013-2018)
Table Global Oncology Molecular Diagnostics Revenue Share by Players (2013-2018)
Figure Global Oncology Molecular Diagnostics Revenue Share by Players in 2016
Figure Global Oncology Molecular Diagnostics Revenue Share by Players in 2017
Figure Global Top 5 Players Oncology Molecular Diagnostics Revenue Market Share in 2017
Figure Global Top 10 Players Oncology Molecular Diagnostics Revenue Market Share in 2017
Figure Global Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Oncology Molecular Diagnostics Revenue (Million USD) by Regions (2013-2018)
Table Global Oncology Molecular Diagnostics Revenue Market Share by Regions (2013-2018)
Figure Global Oncology Molecular Diagnostics Revenue Market Share by Regions (2013-2018)
Figure Global Oncology Molecular Diagnostics Revenue Market Share by Regions in 2017
Figure North America Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Europe Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure South America Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Table North America Oncology Molecular Diagnostics Revenue by Countries (2013-2018)
Table North America Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)
Figure North America Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)
Figure North America Oncology Molecular Diagnostics Revenue Market Share by Countries in 2017
Figure USA Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Canada Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Mexico Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Table Europe Oncology Molecular Diagnostics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Europe Oncology Molecular Diagnostics Revenue Market Share by Countries in 2017
Figure Germany Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure UK Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure France Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Russia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Italy Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Oncology Molecular Diagnostics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Oncology Molecular Diagnostics Revenue Market Share by Countries in 2017
Figure China Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Japan Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Korea Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure India Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Table South America Oncology Molecular Diagnostics Revenue by Countries (2013-2018)
Table South America Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)
Figure South America Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)
Figure South America Oncology Molecular Diagnostics Revenue Market Share by Countries in 2017
Figure Brazil Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Argentina Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Colombia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Oncology Molecular Diagnostics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncology Molecular Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncology Molecular Diagnostics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure UAE Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Egypt Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure Nigeria Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Figure South Africa Oncology Molecular Diagnostics Revenue and Growth Rate (2013-2018)
Table Global Oncology Molecular Diagnostics Revenue (Million USD) by Type (2013-2018)
Table Global Oncology Molecular Diagnostics Revenue Share by Type (2013-2018)
Figure Global Oncology Molecular Diagnostics Revenue Share by Type (2013-2018)
Figure Global Oncology Molecular Diagnostics Revenue Share by Type in 2017
Table Global Oncology Molecular Diagnostics Revenue Forecast by Type (2018-2023)
Figure Global Oncology Molecular Diagnostics Market Share Forecast by Type (2018-2023)
Figure Global PCR Revenue Growth Rate (2013-2018)
Figure Global INAAT Revenue Growth Rate (2013-2018)
Figure Global DNA sequencing & NGS Revenue Growth Rate (2013-2018)
Figure Global In situ hybridization Revenue Growth Rate (2013-2018)
Figure Global DNA microarrays Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Table Global Oncology Molecular Diagnostics Revenue by Application (2013-2018)
Table Global Oncology Molecular Diagnostics Revenue Share by Application (2013-2018)
Figure Global Oncology Molecular Diagnostics Revenue Share by Application (2013-2018)
Figure Global Oncology Molecular Diagnostics Revenue Share by Application in 2017
Table Global Oncology Molecular Diagnostics Revenue Forecast by Application (2018-2023)
Figure Global Oncology Molecular Diagnostics Market Share Forecast by Application (2018-2023)
Figure Global Infectious diseases Revenue Growth Rate (2013-2018)
Figure Global oncology Revenue Growth Rate (2013-2018)
Figure Global Genetic tests Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Figure Global Oncology Molecular Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Oncology Molecular Diagnostics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Oncology Molecular Diagnostics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)
Figure Europe Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)
Figure South America Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Oncology Molecular Diagnostics Revenue Market Forecast (2018-2023)
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...